The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes

AIDS

Volumn 26, Issue 16, 2012, Pages 2017-2026

  Gibellini, Lara ^a   De Biasi, Sara ^a   Pinti, Marcello ^a   Nasi, Milena ^a   Riccio, Massimo ^a   Carnevale, Gianluca ^a   Cavallini, Gian M ^a   Sala De Oyanguren, Francisco J ^b   O'Connor, José E ^b   Mussini, Cristina ^a   De Pol, Anto ^a,c   Cossarizza, Andrea ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

^c S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

apoptosis; atazanavir; autophagy; HAART; ipodystrophy; mitophagy; oxidative stress

Indexed keywords

AMPRENAVIR; ATAZANAVIR; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOCORTIN 5; OXYGEN; PROPIDIUM IODIDE; RITONAVIR; SUPEROXIDE;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYSOSOME; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MITOPHAGY; PLASMID; PRIORITY JOURNAL; PROADIPOCYTE; TRANSMISSION ELECTRON MICROSCOPY;

ADIPOCYTES; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUTOPHAGY; BLOTTING, WESTERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MICROSCOPY, ELECTRON; MITOCHONDRIAL DEGRADATION; OLIGOPEPTIDES; PYRIDINES;

EID: 84867745664     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328359b8be     Document Type: Article

References (40)

1. Caron M, Auclairt M, Vissian A, Vigouroux C, Capeau J. Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues. Antivir Ther 2008; 13:27-38.
2. Galluzzi L, Pinti M, Troiano L, Prada N, Nasi M, Ferraresi R, et al. Changes in mitochondrial RNA production in cells treated with nucleoside analogues. Antivir Ther 2005; 10:191-195.
3. Maggiolo F, Roat E, Pinti M, Nasi M, Gibellini L, De Biasi S, et al. Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients. Antivir Ther 2010; 15:51-59.
4. Nasi M, Pinti M, Chiesa E, Fiore S, Manzini S, Del Giovane C, et al. Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. Antivir Ther 2011; 16:365-372.
5. Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, Pinti M, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003; 32:370-374.
6. Vernochet C, Azoulay S, Duval D, Guedj R, Cottrez F, Vidal H, et al. Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines. J Biol Chem 2005; 280:2238-2243.
7. Wentworth JM, Burris TP, Chatterjee VK. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPAR-gamma/RXR heterodimer. J Endocrinol 2000; 164:R7-R10.
8. Jones SP, Waitt C, Sutton R, Back DJ, Pirmohamed M. Effect of atazanavir and ritonavir on the differentiation and adipokine secretion of human subcutaneous and omental preadipocytes. AIDS 2008; 22:1293-1298.
9. Capel E, Auclair M, Caron-Debarle M, Capeau J. Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes. Antivir Ther 2012; 17:549-556.
10. Caso G, Mileva I, McNurlan MA, Mynarcik DC, Darras F, Gelato MC. Effect of ritonavir and atazanavir on human subcutaneous preadipocyte proliferation and differentiation. Antiviral Res 2010; 86:137-143.
11. Klionsky DJ, Cuervo AM, Dunn WA Jr, Levine B, van der Klei I, Seglen PO. How shall I eat thee? Autophagy 2007; 3:413-416.
12. Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007; 9:1102-1109.
13. Mijaljica D, Prescott M, Devenish RJ. Different fates of mitochondria: alternative ways for degradation? Autophagy 2007; 3:4-9.
14. Nowikovsky K, Reipert S, Devenish RJ, Schweyen RJ. Mdm38 protein depletion causes loss of mitochondrial KR/HR exchange activity, osmotic swelling and mitophagy. Cell Death Differ 2007; 14:1647-1656.
15. Monastyrska I, Klionsky DJ. Autophagy in organelle homeostasis: peroxisome turnover. Mol Aspects Med 2006; 27:483-494.
16. Bernales S, Schuck S, Walter P. ER-phagy: selective autophagy of the endoplasmic reticulum. Autophagy 2007; 3:285-287.
17. Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 2005; 8:3-5.
18. Wang K, Klionsky DJ. Mitochondria removal by autophagy. Autophagy 2011; 7:297-300.
19. Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, et al. Senescence, apoptosis or autophagy? When a damaged cell must decide its path: a mini-review. Gerontology 2008; 54:92-99.
20. Xue LY, Chiu SM, Oleinick NL. Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photody-namic therapy. Autophagy 2010; 6:248-255.
21. Galluzzi L, Morselli E, Vicencio JM, Kepp O, Joza N, Tajeddine N, et al. Life, death and burial: multifaceted impact of auto-phagy. Biochem Soc Trans 2008; 36:786-790.
22. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15:5308-5316.
23. Apostolova N, Gomez-Sucerquia LJ, Gortat A, Blas-Garcia A, Esplugues JV. Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy. Hepatology 2011; 54:1009-1019.
24. Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, Abu-Asab MS, et al. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 2007; 13:5183-5194.
25. Riccio M, Dembic M, Cinti C, Santi S. Multifluorescence labeling and colocalization analyses. Methods Mol Biol 2004; 285:171-177.
26. Mukhopadhyay P, Rajesh M, Hasko G, Hawkins BJ, Madesh M, Pacher P. Simultaneous detection of apoptosis and mitochon-drial superoxide production in live cells by flow cytometry and confocal microscopy. Nat Protoc 2007; 2:2295-2301.
27. Troiano L, Ferraresi R, Lugli E, Nemes E, Roat E, Nasi M, et al. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry. Nat Protoc 2007; 2:2719-2727.
28. Cossarizza A, Ferraresi R, Troiano L, Roat E, Gibellini L, Ber-toncelli L, et al. Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry. Nat Protoc 2009; 4:1790-1797.
29. Gougeon ML, Penicaud L, Fromenty B, Leclercq P, Viard JP, Capeau J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations. Anti-vir Ther 2004; 9:161-177.
30. Lagathu C, Bastard JP, Auclair M, Maachi M, Kornprobst M, Capeau J, et al. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro. Antivir Ther 2004; 9:911-920.
31. Gauthier B, Robb M, Gaudet F, Ginsburg GS, McPherson R. Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a,-2, and YY1. J Lipid Res 1999; 40:1284-1293.
32. Izem L, Morton RE. Cholesteryl ester transfer protein biosynthesis and cellular cholesterol homeostasis are tightly interconnected. J Biol Chem 2001; 276:26534-26541.
33. Pinti M, Gibellini L, De Biasi S, Nasi M, Roat E, O'Connor JE, et al. Functional characterization of the promoter of the human Lon protease gene. Mitochondrion 2011; 11:200-206.
34. Pinti M, Gibellini L, Guaraldi G, Orlando G, Gant TW, Morselli E, et al. Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipody-strophy: implications for the pathogenesis of the disease. AIDS 2010; 24:841-850.
35. Richardson MA, Berg DT, Johnston PA, McClure D, Grinnell BW. Human liposarcoma cell line, SW872, secretes cholesteryl ester transfer protein in response to cholesterol. J Lipid Res 1996; 37:1162-1166.
36. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, et al. Fission and selective fusion govern mitochon-drial segregation and elimination by autophagy. EMBO J 2008; 27:433-446.
37. Jang SY, Kang HT, Hwang ES. Nicotinamide-induced mitophagy: event mediated by NADR/NADH ratio and SIRT1 protein activation. J Biol Chem 2012; 287:19304-19314.
38. Crutchley RD, Ma Q, Sulaiman A, Hochreitter J, Morse GD. Within-patient atazanavir trough concentration monitoring in HIV-1-infected patients. J Pharm Pract 2011; 24:216-222.
39. Tarr PE, Rotger M, Telenti A. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics. Pharmacogenomics 2010; 11:587-594.
40. Nasi M, Pinti M, Bugarini R, Troiano L, Lugli E, Bellodi C, et al. Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4R T cell count after antiretroviral therapy in drug-näive HIV-positive patients. Immunogenetics 2005; 57:628-635.